CSS »

Cyteir Therapeutics shares owned by CSS

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by CSS from 13F filings

Historical chart of CSS investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by CSS

Quarter filed Position value Share count Share price at filing
2023-12-31 $168k 55k 3.04
2023-09-30 $162k 57k 2.84
2023-06-30 $157k 61k 2.60

More positions owned by CSS

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
American Airlines Group Note 6.500% 7/0 (Principal)
Microstrategy Cl A New (MSTR)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Ark Etf Tr Innovation Etf (ARKK)
Ionis Pharmaceuticals Note 4/0 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)
Ncl Corp Note 5.375% 8/0 (Principal)
American Airls (AAL)
Zscaler Note 0.125% 7/0 (Principal)
Microstrategy Note 2/1 (Principal)
Bentley Sys Note 0.125% 1/1 (Principal)
Spdr Gold Tr Gold Shs (GLD)

View all positions for CSS

Top funds holding Cyteir Therapeutics

BML Capital Management
Acadian Asset Management
Boston Family Office
Lindbrook Capital

View all funds holding Cyteir Therapeutics